|
|
||||||||
The Journal of Immunology, Vol 154, Issue 2 780-789, Copyright © 1995 by American Association of Immunologists
ARTICLES |
CH Tay, RM Welsh and RR Brutkiewicz
Department of Pathology, University of Massachusetts Medical Center, Worcester 01655.
Because class I MHC Ags have been implicated as modulators of target cell sensitivity to NK cell-mediated lysis, the regulation of virus infections and the fate of NK cells and their natural targets was examined in beta 2-microglobulin-deficient mice, which have defective class I MHC expression. Infections with either the NK cell-sensitive murine cytomegalovirus (MCMV) or the NK cell-resistant lymphocytic choriomeningitis virus (LCMV) significantly augmented NK cell activity in either C57BL/6 (+/+) or beta 2-microglobulin knockout (-/-) mice. Depletion of NK cells in vivo with antiserum to asialo-GM1 markedly enhanced the synthesis of MCMV but had no effect on the synthesis of LCMV in either strain of mouse. Analysis of naturally NK cell-sensitive thymocyte targets from these virus-infected -/- mice revealed no cell surface expression of class I MHC detectable by conformation-dependent or -independent Abs, but the virus infections enhanced class I expression on thymocytes from +/+ mice. The sensitivity of +/+ thymocytes to NK cell-mediated lysis was markedly reduced after in vivo poly inosinic:cytidylic and treatment or viral infection; in contrast, the sensitivity of the -/- thymocytes was significantly less affected by poly inosinic:cytidylic acid treatment or viral infection. These data indicate that the normal expression of class I MHC Ags on NK cells or their targets is not required for the antiviral functions of NK cells against a NK-sensitive virus (MCMV) nor do they protect a NK- resistant virus (LCMV) from the antiviral activity of NK cells.
This article has been cited by other articles:
![]() |
S. Guia, C. Cognet, L. de Beaucoudrey, M. S. Tessmer, E. Jouanguy, C. Berger, O. Filipe-Santos, J. Feinberg, Y. Camcioglu, J. Levy, et al. A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo Blood, May 15, 2008; 111(10): 5008 - 5016. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Goldszmid, A. Bafica, D. Jankovic, C. G. Feng, P. Caspar, R. Winkler-Pickett, G. Trinchieri, and A. Sher TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-{gamma} production J. Exp. Med., October 29, 2007; 204(11): 2591 - 2602. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Crotty, M. M. McCausland, R. D. Aubert, E. J. Wherry, and R. Ahmed Hypogammaglobulinemia and exacerbated CD8 T-cell-mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP disease Blood, November 1, 2006; 108(9): 3085 - 3093. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dighe, M. Rodriguez, P. Sabastian, X. Xie, M. McVoy, and M. G. Brown Requisite H2k Role in NK Cell-Mediated Resistance in Acute Murine Cytomegalovirus-Infected MA/My Mice J. Immunol., November 15, 2005; 175(10): 6820 - 6828. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Fernandez, E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux, and D. H. Raulet A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules Blood, June 1, 2005; 105(11): 4416 - 4423. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Cavanaugh, Y. Deng, M. P. Birkenbach, J. S. Slater, and A. E. Campbell Vigorous Innate and Virus-Specific Cytotoxic T-Lymphocyte Responses to Murine Cytomegalovirus in the Submaxillary Salivary Gland J. Virol., February 1, 2003; 77(3): 1703 - 1717. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Arase, E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors Science, May 17, 2002; 296(5571): 1323 - 1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Johnson, S. Hong, L. Van Kaer, Y. Koezuka, and B. S. Graham NK T Cells Contribute to Expansion of CD8+ T Cells and Amplification of Antiviral Immune Responses to Respiratory Syncytial Virus J. Virol., March 27, 2002; 76(9): 4294 - 4303. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-X. Holterman, K. Rogers, K. Edelmann, D. M. Koelle, L. Corey, and C. B. Wilson An Important Role for Major Histocompatibility Complex Class I-Restricted T Cells, and a Limited Role for Gamma Interferon, in Protection of Mice against Lethal Herpes Simplex Virus Infection J. Virol., March 1, 1999; 73(3): 2058 - 2063. [Abstract] [Full Text] |
||||
![]() |
I. A. Khan, T. Matsuura, and L. H. Kasper Inducible Nitric Oxide Synthase Is Not Required for Long-Term Vaccine-Based Immunity Against Toxoplasma gondii J. Immunol., September 15, 1998; 161(6): 2994 - 3000. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zimmer, L. Donato, D. Hanau, J.-P. Cazenave, M.-M. Tongio, A. Moretta, and H. d. l. Salle Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome) J. Exp. Med., January 5, 1998; 187(1): 117 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sjolin, E. Tomasello, M. Mousavi-Jazi, A. Bartolazzi, K. Karre, E. Vivier, and C. Cerboni Pivotal Role of KARAP/DAP12 Adaptor Molecule in the Natural Killer Cell-mediated Resistance to Murine Cytomegalovirus Infection J. Exp. Med., March 25, 2002; 195(7): 825 - 834. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |